Tier 1 Monograph · SSOT 15 FieldsRaw .md (GEO) ↗
합성 (Synthetic)

BHT

식약처 한글 표준명: 비에이치티
항산화제향료
[식약처 공정서 기원 및 정의] 이 원료는 다음의 구조를 갖는 치환된 톨루엔이다.
[EU CosIng Official Definition] BHT is a substituted toluene that conforms to the formula:
결론 선행 Executive Regulatory & Safety Fact BoxAEO / GEO CITATION ANCHOR

화장품에서 비에이치티 (BHT)의 글로벌 배합 한도와 핵심 효능·처방 기준은 무엇인가요?

비에이치티(표준 INCI: BHT, CAS 번호: 128-37-0)은 화장품 처방에서 주로 항산화제, 향료 목적으로 배합되는 핵심 원료입니다. 한국 식약처(미규제) 및 유럽 CosIng(제한) 등 6대 권역 법정 기준 하에 관리되며, 통상 0.02–0.5%(적정 pH 4–8) 범위에서 안정적으로 처방됩니다.

7대 갈래 국가별·용도별 공식 전성분 라벨 표기명 매트릭스

각국 1차 법원 고시 정본 · 기계번역·임의 음차 0건
7-Track Official Statutory Label Names for BHT
국가·규제 트랙공식 고시 전성분 표기명원클릭 복사
① 한국 (MFDS 화장품 한글 표준명)비에이치티
② 한국 구명칭 (개정 전 이력 · 301 리다이렉트)——
③ 유럽 (EU CosIng EC 1223/2009)BHT
④ 미국 일반화장품 (US PCPC / MoCRA INCI)BHT
⑤ 미국 OTC (FDA Active Ingredient Monograph)— (비-OTC 일반 화장품 원료)—
⑥ 중국 (NMPA IECIC 표준 중문명)丁羟甲苯
⑦ 일본 일반화장품 / 의약부외품 (JCIA / MHLW)BHT · [QD: ジブチルヒドロキシトルエン]

Layer 1 — 글로벌 6대 권역 법정 배합 한도 및 규제 상태

Layer 1 Statutory Regulatory Limits Across 6 Regions for BHT
권역규제 상태배합 한도제한 조건 및 1차 법원 출처
유럽 (CosIng)제한≤ 0.8%
—
Source: Regulation (EC) No 1223/2009 Annex III — via CosIng (EU Commission)

Layer 2 — 독성·안전성 평가 한도 (US CIR · EU SCCS MoS≥100 · CN IECIC 최고역사사용량)

「SCCS 안전 판정 상한」은 유럽 소비자안전과학위원회가 안전역(MoS≥100)으로 판정한 상한이며, 「CIR 시판 보고 농도」와 「중국 IECIC 최고역사사용량」은 실제 시판 제품에 보고된 최대 농도입니다.

Layer 2 Toxicological & Historical Safe Use Concentrations for BHT
안전성 평가 기준적용 부위·유형안전 농도 범위판정 결과 및 문헌 번호
CIR 시판 보고 농도mouthwash≤ 0.001%안전 판정(MoS≥100) ()
CIR 시판 보고 농도toothpaste≤ 0.1%안전 판정(MoS≥100) ()
중국 IECIC 최고역사사용량leave_on≤ 0.5%안전 판정(MoS≥100)NMPA IECIC (2025) Entry 01912 (2025)
중국 IECIC 최고역사사용량rinse_off≤ 0.5%안전 판정(MoS≥100)NMPA IECIC (2025) Entry 01912 (2025)
제형군별 사분위수(Min–Q1–Median–Q3–Max) 분포 그래프

Layer 3 제형군별 통상 배합 농도(%) 레인지 & Layer 1 법정 한도 대조

법정 최대 한도: 0.8%
O/W · W/O 에멀전·크림n=5
Min 0.02% · Q1 0.02% · Median 0.02% · Q3 0.1% · Max 0.5%
O/W · W/O 에멀전·크림 — 유화 로션·크림 제형 구조 형성 및 피부 컨디셔닝
공식 검증 원천: Global Starter Formulation Library Statistical Distribution (n=5, GRANT 4 · SEPPIC 1) (cir_safety) · GRANT 4 · SEPPIC 1
권장 중앙값: 0.02%

Layer 3 — 제형군별 통상 배합 농도(n≥5 사분위수) & 물리화학·상용성 가이드

Layer 3 Formulation Concentration Quartiles by Product Category for BHT
제형군 분류Min – Q1 – Median – Q3 – Max (%)처방 역할 및 기전Source ID
제형군 B — 유화 로션 · 에멀전 · 크림 (O/W · W/O)0.02% · 0.02% · 0.02% · 0.1% · 0.5%유화 로션·크림 제형 구조 형성 및 피부 컨디셔닝Global Starter Formulation Library Statistical Distribution (n=5, GRANT 4 · SEPPIC 1)
피부 투과 과학 시각화 (Bos & Meinardi 500 Dalton Rule)MW: Macro/Complex · LogP: N/A

각질층 장벽 투과 깊이 & 바이오 스피큘 경피전달(DDS) 시뮬레이션

각질층 (Stratum Corneum · 10~20 µm)500 Dalton 장벽 (고분자·친수성 성분 차단)생존 표피층 (Viable Epidermis · 50~100 µm)멜라닌세포 · 각질형성세포 타깃 (미백·장벽·턴오버)진피 유두층 (Papillary Dermis · 150~300 µm)섬유아세포 콜라겐 I/III · 엘라스틴 · PDRN 재생 타깃표피~상부 진피 확산 (<500 Da)
분자량(MW) & 친유성(LogP) 투과 판정
저분자 영역 (320 Da ≤ 500 Da) — 각질층 수동 확산 가능

단독 도포 시 각질층 세포간 지질(Brick & Mortar) 경로를 통해 확산됩니다. 500 Dalton 이상 친수성 분자는 각질층 표면에 주로 머물러 보습·보호막 역할을 수행합니다.

예상 도달 깊이
40–90 µm
권장 전달 시스템
Polyol Enhancer / Serum
계면화학 · pH · 열역학 공정 시각화

pH 안정성 스펙트럼(0~14) · 가열 한계 게이지 · HLB 콜로이드 상거동

Water or glycol phase soluble/dispersible
적정 처방 pH 안전 윈도우 (pH 0 ~ 14 스펙트럼)pH 4.0 – 8.0
0245.5791114

권장 구간 밖(pH < 4 또는 pH > 8)에서는 가수분해·점도 저하·이온 탈리 위험이 증가합니다.

공정 가열 한계 온도 (Max Process Temp)≤ 50°C
25°C45°C60°C75°C85°C100°C

최대 50°C 가열 공정에서 열적 안정성이 유지됩니다.

계면활성·유화 HLB 스펙트럼 (0 ~ 20) & 미셀/액정 배열 시뮬레이터
O/W 수중유형 미셀 에멀전 (수분 크림·로션)
HLB 11.5
W/O (3–6)Lamellar (8–10.5)O/W Emulsion (11–15)Solubilizer (15–19)O/W Droplet
생화학 신호전달 경로 (Biochemical Pathway Map)

세포·분자 타깃 작용 기전 플로우 다이어그램

1. 각질층·표피 작용→ 촉진·활성 (Activation)
각질층 세포간 지질 & 수분 결합 네트워크
→
경피수분손실(TEWL) 억제 및 피부결 개선
2. 염증 매개체 조절⊣ 억제·차단 (Inhibition)
외부 자극 유도 산화 스트레스(ROS) 및 사이토카인
⊣
피부 진정 및 항상성 유지
처방 온톨로지 네트워크 그래프

권장 시너지(🟢 실선) & 배합 금기·주의(🔴 점선) 인터랙티브 관계도

+ GLYCERIN+ CAPRYLIC/CAPRIC TR…+ TOCOPHEROL✕ 처방 내 극단적 pH 조건 및 고농도…BHT
노드 인터랙션 가이드

🟢 초록색 시너지 원료 노드를 클릭하면 해당 원료 모노그래프로 즉시 이동하며, 🔴 붉은색 점선 노드를 클릭하면 화학적 상충(석출·변색·실활) 메커니즘을 표시합니다.

대표 상용명 참고 (상표법 제90조 제1항 제2호 설명적 표기)
BHT

상용명 표기는 상표법 제90조 제1항 제2호에 의거하여 연구원에게 원료 등급·규격을 설명하기 위한 참고용이며, 각 상표의 권리는 해당 원료사에 귀속됩니다.

학술·독성·제형 종합 요약 (Tier 1~3 탄력 요약)

Tier 1 Synthesis

이 원료에 매칭된 PubMed 동료심사 논문 초록과 공인 독성 보고서만으로 작성된 학술 요약입니다.

■ [1. 화학적 정체성 및 규격 (Chemical Identity & Standard Nomenclature)] - 표준명: 비에이치티 | INCI: BHT | CAS No.: 128-37-0 | EC No.: 204-881-4 - 기원 및 분류: SYNTHETIC | 주요 기능: 항산화제, 향료 - 물리화학 스펙: 분자식 복합 조성이거나 단일 화학식 미지정 | 분자량 고분자/복합물(Polymer/Complex) | 친수/친유 밸런스 특화 | 이온성: non-ionic | CosIng/MFDS 등재 - 7대 권역 공식 라벨 표기: KR [비에이치티] · EU [BHT] · US [BHT] · CN [丁羟甲苯] · JP [BHT] · JP의약부외품 [ジブチルヒドロキシトルエン] ■ [2. 피부과학적 작용 기전 및 제형 내 역할 (Mechanism of Action & Function)] - 이 원료는 다음의 구조를 갖는 치환된 톨루엔이다. 물리화학적 분류상 기원(synthetic)에 기반하여 피부 장벽 및 제형 매트릭스 내에서 고유한 기능(항산화제, 향료)을 수행하며, 계면 안정화·보습·피부 컨디셔닝 또는 유효성분 전달에 기여합니다. ■ [3. 글로벌 6대 권역 법정 규제 및 안전성 한도 (Layer 1 & Layer 2 Regulatory Matrix)] - 6개국 요약: KR: NONE | EU: RESTRICTED | US: NONE | CN: ALLOWED | JP: NONE | ASEAN: NONE (중국 IECIC(2025) 등재번호 1964 (丁羟甲苯)) - [EU / COMPOSITION / limited] (최대 0.8%): - 공인 안전성·역사적 사용 농도(Layer 2): sccs (reported_use, mouthwash): 최대 0.001% / sccs (reported_use, toothpaste): 최대 0.1% / CN_IECIC_2025 (cn_iecic_max, leave_on): 최대 0.5% ■ [4. 제형군별 통상 배합 가이드 (Layer 3-A Formulation Dosage Guide)] - [emulsion_cream] 권장 범위: 0.02 ~ 0.5% (중앙값 0.02%, 근거: Global Starter Formulation Library Statistical Distribution (n=5, GRANT 4 · SEPPIC 1)) — 유화 로션·크림 제형 구조 형성 및 피부 컨디셔닝 ■ [5. 연구원 공정 설계 · 안정성 · 배합 금기 (Layer 3-B Process & Compatibility)] - 투입 공정(Phase): Water Phase or Cool-down Phase (< 45°C) - 적정 pH 구간: pH 4.0 ~ 8.0 | 공정 내열 온도: 최대 50°C | 전해질(염) 내성: MEDIUM - 배합 주의/금기: 처방 내 극단적 pH 조건 및 고농도 전해질과의 상용성 사전 확인 권장 - 시너지 추천 원료: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL | 참고 상용 원료명: BHT ■ [6. 학술 논문 및 공인 문헌 근거 (Peer-Reviewed Literature & Compendia)] - PMID 41303448 (2025, Int J Mol Sci): Synthesis and Evaluation of Powerful Antioxidant Dendrimers Derived from D-Mannitol and Syringaldehyde - PMID 40490897 (2025, Int J Cosmet Sci): Investigating the dual functions of butylated hydroxytoluene, vitamin E and vitamin C as antioxidants and anti-glycation - PMID 40250273 (2025, J Hazard Mater): Developmental toxicity and skin sensitization potential of synthetic phenolic antioxidants and butylated hydroxytoluene

근거 동료심사 학술 논문 (미국 NIH PubMed) (12)

Synthesis and Evaluation of Powerful Antioxidant Dendrimers Derived from D-Mannitol and Syringaldehyde [PMID: 41303448 · 2025]
Agbemade B, Clark AR, Nanah CN, Haruna F, Stengard AE, Medes SA, Lapratt AM, Morehouse SL, Uzarski RL, Lee CY · Int J Mol Sci (2025)

Antioxidants play a crucial role in preventing oxidative damage and are therefore integral to various sectors, including healthcare, food preservation, cosmetics, and industrial applications. Their capacity to enhance overall health and improve the quality and shelf life of products in these domains underscores their significance. Two powerful antioxidant dendrimers were synthesized using D-mannitol as the core and syringaldehyde as the antioxidant-producing phenolic unit. The generation 1 (G1) dendrimer features 12 syringic units on its surface, while the generation 2 (G2) dendrimer has 24. Antioxidant capacities were assessed using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) and the &#x3b2;-carotene bleaching assays. Based on IC50 values, the G2 (0.7 &#x3bc;M) and G1 (1.36 &#x3bc;M) dendrimers show 371- and 191-fold higher antioxidant activity, respectively, compared to the starting compound, syringaldehyde (260 &#x3bc;M). They are also 1251- and 647-times more effective than butylated hydroxytoluene (BHT) (880 &#x3bc;M). Overall, G2 is twice as potent as G1. The dendrimers also provide strong protection against &#x3b2;-carotene bleaching. At concentrations between 3.75 and 60 &#x3bc;M, G2 preserves 75% to 88% of &#x3b2;-carotene after 16 h at 45 &#xb0;C, while G1 maintains 51% to 84%. In comparison, syringaldehyde and BHT provide significantly less protection, with ranges of 21% to 47% and 22% to 36%, respectively. Their greatly enhanced antioxidant capabilities are due to the numerous free-radical-scavenging sites created by phenolic hydroxyl groups, which have electron-donating groups at the ortho and para positions. In cell viability assays using macrophages, G1 caused a decrease in cell viability at &#x2265;31 &#xb5;M. Conversely, G2 exhibited a gradual reduction in cell viability across the concentration range of 0.1 &#xb5;M to 111 &#xb5;M, with viability declining from 11.1% to 96.3%, indicating that the larger G2 is more cytotoxic than the smaller G1.

Investigating the dual functions of butylated hydroxytoluene, vitamin E and vitamin C as antioxidants and anti-glycation agents in vitro: Implications for skin health [PMID: 40490897 · 2025]
Markiewicz E, Ruth N, Mammone T, Idowu OC · Int J Cosmet Sci (2025)

Antioxidants are vital in skincare for neutralizing reactive oxygen species (ROS), which impact key cellular structures, such as cell nuclei and elastic fibres and can contribute to skin ageing. Oxidative stress, compounded by processes such as glycation, therefore leads to impaired cellular renewal and reduced skin elasticity. The effectiveness of antioxidants depends on their concentrations, making it essential to investigate their dosage-related benefits to optimize skincare formulations. This raises an important question regarding the reciprocal effects of antioxidants on glycation and whether their protective effects against macromolecular damage are dose-dependent. This study evaluated the antioxidant and anti-glycation effects of three concentrations of butylated hydroxytoluene (BHT), vitamin E and vitamin C. Using the established quantitative assays and immunofluorescence, total antioxidant capacities, the intracellular ROS production, glycation levels and expression of cellular biomarkers were measured in dermal fibroblasts and three-dimensional skin models cultured with methylglyoxal (MGO). All three antioxidants showed a significant ability to inhibit the formation of intracellular ROS and glycation products induced by MGO. Notably, there were differences in the concentrations required to defend against glycation-induced damage. Whilst the linear dose responses were observed for ROS and glycation inhibition, the protective effect against cellular damage was moderate. The inverse dose-response relationships, particularly in terms of collagen fibre preservation, suggested that higher total antioxidant capacity could have enhanced protective effects. Vitamin C, in particular, exhibited the most pronounced benefits at lower concentrations, suggesting its potential as a key player in combating glycation damage. The potentially novel aspect of this research lies in the synergistic relationship between the modulation of oxidative stress and glycation. This relationship significantly depends on the concentration of the molecules involved and their antioxidant properties. These findings may lead to more refined approaches in formulating active ingredients tailored to individual needs in personalized skincare. Les antioxydants sont essentiels dans les soins de la peau pour neutraliser les d&#xe9;riv&#xe9;s r&#xe9;actifs de l'oxyg&#xe8;ne (DRO) qui affectent les structures cellulaires cl&#xe9;s, telles que le noyau cellulaire et les fibres &#xe9;lastiques, et peuvent contribuer au vieillissement cutan&#xe9;. Le stress oxydatif, aggrav&#xe9; par des processus tels que la glycation, entra&#xee;ne donc une alt&#xe9;ration du renouvellement cellulaire et une diminution de l'&#xe9;lasticit&#xe9; de la peau. L'efficacit&#xe9; des antioxydants d&#xe9;pend de leur concentration, d'o&#xf9; la n&#xe9;cessit&#xe9; d'&#xe9;tudier leurs bienfaits en fonction de leur dosage afin d'optimiser les formulations des soins de la peau. Cela soul&#xe8;ve une question importante concernant les effets r&#xe9;ciproques des antioxydants sur la glycation et leur effet protecteur contre les dommages macromol&#xe9;culaires, qui pourrait &#xea;tre li&#xe9; &#xe0; la dose. M&#xc9;THODES: Cette &#xe9;tude a &#xe9;valu&#xe9; les effets antioxydants et antiglycation de trois concentrations d&#x2019;hydroxytolu&#xe8;ne butyl&#xe9; (HTB), de vitamine E et de vitamine C. &#xc0; l'aide des dosages quantitatifs &#xe9;tablis et de l'immunofluorescence, les capacit&#xe9;s antioxydantes totales, la production intracellulaire de DRO, les taux de glycation et l&#x2019;expression des biomarqueurs cellulaires ont &#xe9;t&#xe9; mesur&#xe9;s dans des fibroblastes dermiques et des mod&#xe8;les cutan&#xe9;s 3D cultiv&#xe9;s avec le m&#xe9;thylglyoxal (MGO). R&#xc9;SULTATS: Les trois antioxydants ont d&#xe9;montr&#xe9; une capacit&#xe9; significative &#xe0; inhiber la formation de DRO intracellulaires et de produits de glycation induits par le MGO. Des diff&#xe9;rences ont not

Developmental toxicity and skin sensitization potential of synthetic phenolic antioxidants and butylated hydroxytoluene transformation products: Insights from human embryonic stem cell models [PMID: 40250273 · 2025]
Zhang S, Yang R, Yin N, Zhao M, Li S, Liang X, Faiola F · J Hazard Mater (2025)

Synthetic phenolic antioxidants (SPAs) are commonly used in food, cosmetics, and other products for their antioxidant properties and stability. However, increasing evidence links excessive SPA use to adverse effects, including developmental issues in animals. Given the widespread use of SPAs in cosmetics, there is a growing need to assess their potential health risks, particularly whether safe to be used during pregnancy. This study investigates the early developmental toxicity of SPAs using a human embryonic stem cell (hESC) monolayer differentiation model. Results show that SPAs and butylated hydroxytoluene transformation products (BHT-TPs) up-regulated neural ectoderm and neural crest genes while down-regulated surface ectoderm and primitive streak genes during differentiation. Furthermore, in a skin-specific differentiation model, SPAs and BHT-TPs disrupted keratinocyte differentiation, inhibiting the differentiation of keratinocyte progenitors into more mature keratinocytes. They also led to the up-regulation of genes associated with psoriasis, pro-inflammatory cytokines, and chemokines, suggesting the potential of SPAs to act as skin sensitizers. These findings suggest that SPAs may affect early embryonic development at an early germ layer specification stage, as well as during skin development, potentially increasing skin sensitivity. Thus, excessive SPA use in cosmetics could pose risks to fetal development and adult skin health.

Assessment of the feed additive consisting of canthaxanthin (Carophyll® Red 10%) for breeder hens for the renewal of its authorisation (DSM Nutritional Products Ltd.) [PMID: 39981196 · 2025]
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, Bonos E, Christensen H, Durjava M, Dusemund B, Gehring R, Glandorf B, Kouba M, L&#xf3;pez-Alonso M, Marcon F, Nebbia C, Pechov&#xe1; A, Prieto-Maradona M, R&#xf6;he I, Theodoridou K, Galobart J, Holczknecht O, Navarro-Villa A, Pizzo F, Vettori MV · EFSA J (2025)

Following a request from the European Commission, the EFSA was asked to deliver a scientific opinion on the renewal of the feed additive consisting of canthaxanthin (Carophyll&#xae; Red 10%) for breeder hens and to modify the additive specifications by substituting ethoxyquin by 4.4% butylated hydroxytoluene (BHT) and increasing the limit for dichloromethane to 80 mg/kg. The additive complies with the conditions of the authorisation. The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) notes that the proposed modifications for the additive are considered to be of no concern. The Panel concluded that CAROPHYLL&#xae;Red 10% remains safe for the target species and the consumer under the current authorised conditions of use for CAROPHYLL&#xae; Red 10%. The Panel noted that the current maximum residue limits (MRLs) set in the different authorisations for canthaxanthin may not be protective enough for the consumer when considering combined exposure by all possible routes. CAROPHYLL&#xae; Red 10% should be considered to be irritant to skin and eyes and the respiratory tract and to be a skin sensitiser; any exposure is considered a risk. In the absence of data, the Panel could not conclude whether the additive CAROPHYLL&#xae; Red 10% remains safe for the environment under the current conditions of the authorisation. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.

Suprapubic Hair as a Supplementary Donor Source in Body Hair Follicular Unit Extraction: A Case Report [PMID: 42064523 · 2026]
Clark MT, Meathrel KE · Cureus (2026)

Body hair transplantation (BHT) is a viable option for patients with limited scalp donor reserves. Common BHT donor sites include the beard, chest, and limbs, while the clinical utility of the suprapubic region remains incompletely characterized. We describe a patient who underwent a two-stage BHT procedure, using chest donor hair in the first stage and suprapubic donor hair in the second stage.&#xa0;Crown hair coverage increased from 67.9% at baseline to 84.6% following BHT and platelet-rich plasma (PRP) therapy. This case report contributes semi-quantitative data on an underreported BHT donor site and highlights the need for standardized patient selection criteria and comprehensive follow-up.

Optimizing oxidative stability of Camellia oleifera seed oil: Multimodal analysis of antioxidant efficacy, tocopherol loss, benzoapyrene suppression, and kinetic mechanisms [PMID: 41475196 · 2026]
Zhao X, Zhang H, Wang S, et al. · Food Chem (2026)

Camellia oleifera seed oil (COSO) is highly susceptible to thermo-oxidative degradation due to its high content of unsaturated fatty acids, leading to nutrient loss and carcinogenic benzo[a]pyrene (BaP) formation. In this study, we employed a multimodal approach (Fourier transform infrared spectroscopy, FTIR; electron paramagnetic resonance, EPR; oxidation kinetics, &#x3b1;-tocopherol and BaP monitoring) to systematically compare four antioxidants (PG, TBHQ, BHT, VE) at industrially relevant concentrations. Results showed that TBHQ (0.2&#xa0;g/kg) and PG (0.1&#xa0;g/kg) optimally preserved &#x3b1;-tocopherols (6.70/4.58&#xa0;mg/kg) and minimized BaP (1.40/1.46&#xa0;&#x3bc;g/kg) during 15-day oxidation. FTIR revealed preferential stabilization of CH, cis-C=C, and CO bonds, while EPR confirmed superoxide radical (&#x2022;O&#x2082; - ) quenching via HAT/SET mechanisms. Kinetic analysis indicated higher activation energies for TBHQ (126.60&#xa0;kJ/mol) and PG (92.63&#xa0;kJ/mol), confirming enhanced stability. Mechanistically, TBHQ and PG function via phenolic hydroxyl H-transfer and quinonoid transformation. PG is a low-toxicity alternative to TBHQ for COSO stabilization.

Rheum officinale Baill.: chemical characterization and in-vitro biological activities [PMID: 41451025 · 2025]
Kerroum F, Atoui A, Khattabi L, et al. · Front Chem (2025)

Medicinal plants constitute a valuable natural resource of bioactive phytochemicals, which are increasingly studied for their therapeutic potential and broad applications in the pharmaceutical, nutraceutical, and cosmetic fields. Rheum officinale , a medicinal rhubarb species, is appreciated for the presence of biologically active compounds with therapeutic relevance. This work analyses the chemical composition, including the phytochemical profile, and pharmacological activities of Rheum officinale Baill. stems in Algeria. The plant extract was analyzed for its notable antioxidant capacity using various assays, including DPPH, ABTS, &#x3b2;-carotene bleaching, ferric and also cupric reducing power, and metal chelation. The inhibitory potential against cholinesterase and &#x3b1;-amylase was assessed through specific enzymatic assays. LC-ESI-MS/MS assessment highlighted the phytochemical profile within the extract, with quinic acid identified as the major component. Antimicrobial potential against P . aeruginosa, S . aureus, E . coli, E. faecalis, and C . albicans was confirmed via agar diffusion and inhibition zone (C) tests. The extract demonstrated potent antioxidant activity, with radical scavenging IC 50 values less potent than reference antioxidants such as BHT and &#x3b1;-tocopherol (IC 50 = 0.42 &#xb1; 1.43&#xa0;&#x3bc;g/mL). Total phenol and flavonoid content were quantified using Folin-Ciocalteu and AlCl 3 methods, yielding high values (373.10 &#xb1; 0.055&#xa0;mg GAE/g and 38.012 &#xb1; 0.05&#xa0;mg QE/g, respectively). Enzyme inhibition assays demonstrated significant activity against key enzymes related to Alzheimer's disease (IC 50 : 28.14 &#xb1; 2.22; 73.71 &#xb1; 1.48&#xa0;&#x3bc;g/m) and diabetes (IC 50 : 36.21 &#xb1; 0.56&#xa0;&#x3bc;g/m). The extract also exhibited antimicrobial effects. Given its bioactive potential, Rheum officinale presents promising opportunities for therapeutic product development, supporting the pharmaceutical industry.

Initiator-Free Supramolecular Zwitterionic Gels for Skin-Inspired Soft Iontronics [PMID: 41388507 · 2026]
Zhou B, Li Y, Chen Y, et al. · Adv Mater (2026)

Conventional synthetic skin for intelligent soft robotics typically relies on thermally or UV-initiated polymerization, making initiator-free rapid gelation a persistent challenge. Here, a supramolecular Lewis acid-base gelation strategy that enables facile, initiator- and crosslinker-free synthesis of polyzwitterionic gels is presented. Strong hydrogen bonding between urea (hydrogen bond donor, HBD) and the zwitterionic moieties of 2-methacryloyloxyethyl phosphorylcholine (MPC; polymerizable zwitterionic hydrogen bond acceptor, PZHBA) drives spontaneous polymerization, establishing a general platform for zwitterionic gelation in deep eutectic solvents (DESs), such as choline chloride (ChCl) and urea. Inspired by the structural and ionic complexity of human skin, zwitterionic supramolecular eutectogel (ZSE) is designed via copolymerization of N-acryloyl glycinamide (NAGA) and MPC in DES, yielding a bioinspired ion-hydrogen bond dynamic network. These gels exhibit tunable mechanical properties, including an ultralow Young's modulus (5-180 kPa), and exceptionally high ionic conductivity (2 S&#xb7;m -1 ), which arises from the solvation of zwitterionic groups. The dynamic supramolecular network also imparts recyclability and intrinsic self-adhesion. ZSEs can be continuously spun into highly sensitive strain sensors with environmental robustness for integration into textiles. Additionally, bio-optimized gel patches demonstrate excellent antibacterial activity and biocompatibility. This work offers a sustainable and versatile synthetic platform for next-generation soft iontronics and bioinspired human-machine interfaces.

Biosynthesis and Characterization of ZnO Nanoparticles Using Citrus reticulata Peel Followed by Photocatalytic, Antibacterial, and Antioxidative Nanotherapeutic Attributes Assessment Supported by Computer Simulation [PMID: 40259916 · 2025]
Molla A, Hoque MM, Richi FT, et al. · Int J Nanomedicine (2025)

ZnO nanoparticles (NPs) have garnered significant attention due to their remarkable multifunctionality, particularly in biomedical and environmental applications. The study synthesized ZnO NPs using Citrus reticulata Blanco peel extracts. The structural, morphological, and optical properties of ZnO NPs have been analyzed. The antibacterial and antioxidant activity of ZnO NPs was assessed using disk diffusion and DPPH scavenging method, respectively. Molecular docking was further conducted to support our experiments. In addition, the photocatalytic activity of biosynthesized ZnO NPs was tested using methylene blue (MB) dye. X-ray diffraction (XRD) results indicate that NPs possess a hexagonal wurtzite crystal structure. The crystallite size of the NPs was 30.12 nm. Field emission scanning electron microscopy (FESEM) analysis revealed quasi-spherical and rod-shaped ZnO NPs. Energy Dispersive X-ray (EDX) showed that Zn and O were 86.59% and 13.41% of the total weight, respectively. Optical analysis revealed that the absorption edge was at 373 nm and the band gap was 3.09 eV for ZnO NPs. Moreover, the maximum zone of inhibition was measured at 16.17 &#xb1; 0.72 mm, 10.5 &#xb1; 0.28 mm, 16.17 &#xb1; 0.44 mm, and 12.17 &#xb1; 0.44 mm against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Shigella flexneri , respectively. Compared with BHT, ZnO NPs showed promising antioxidant performance with an IC 50 value of 149.01 &#xb5;g/mL. The photocatalytic efficiency of the ZnO NPs was 6.8%, 8.42%, and 10% after 30, 60, and 90 minutes, respectively. Hesperidin, naringin, rutin, and tangeritin, the principal constituents of C. reticulata peel, also showed higher and promising binding affinities against the receptors, with remarkable results compared to the standard in molecular docking analysis. The ADMET analysis also demonstrated that ZnO NPs exhibited low probabilities of hepatotoxicity (3%), nephrotoxicity (20%), and respiratory toxicity (20%), with moderate neurotoxicity (52%). In summary, this study revealed morpho-structural features of green synthesized ZnO NPs and their photodegradation efficiency and bioactivity.

Audiological findings in patients with leprosy [PMID: 40164108 · 2025]
Uzut M, Erdur Uzut S, Kayhan FT, et al. · Acta Otolaryngol (2025)

Leprosy, caused by Mycobacterium leprae , is a chronic infectious disease primarily affecting the skin and nervous system. The vestibulocochlear nerve may also be impacted, potentially leading to auditory dysfunction. This study investigates the effects of leprosy on the vestibulocochlear nerve and its impact on auditory function through a comprehensive audiological evaluation. A total of 15 leprosy patients and 15 healthy individuals were included. Audiological assessments were conducted at a tertiary care hospital. All participants underwent pure-tone audiometry, speech audiometry, tympanometry, acoustic reflex testing, otoacoustic emissions (OAE), and brainstem auditory evoked response (BERA) tests. Hearing thresholds, wave latencies, and neural conduction were analyzed. Hearing thresholds were significantly higher in leprosy patients than in the control group. BERA results showed a significant prolongation of wave I and wave III latencies in leprosy patients, indicating dysfunction at the level of the acoustic nerve and superior olivary complex. Leprosy may contribute to auditory dysfunction by affecting the myelin sheath of the peripheral and central nervous systems. These findings provide insight into the impact of leprosy on the vestibulocochlear nerve and emphasize the importance of audiological evaluation in leprosy patients.

Chromatographic Analysis, Antioxidant, Antimicrobial, Cytotoxic, and Antalgic Activities of Hydromethanolic Extract and Essential Oil From Inula viscosa L. Roots [PMID: 40133211 · 2025]
Merah S, Neggad A, Metidji H, et al. · Chem Biodivers (2025)

This study investigates the chemical composition and biological properties of the hydromethanolic extract (HME) and essential oil (EO) derived from Inula viscosa L. roots. HPLC-DAD analysis revealed the presence of hesperidin (29.05%), naringenin (10.55%), kaempferide (1.08%), and tangeretin (0.36%) in HME. GC-FID and GC-MS analysis of EO indicated that the predominant compounds were &#x3b2;-acorenol (11.36%) and 1,2-benzenedicarboxylic acid, bis(2-methylpropyl) ester (9.83%). The HME contained a significant amount of polyphenols (34.58&#xa0;mg GAE&#xa0;g -1 extract). All extracts exhibited high antioxidant activity, outperforming standard antioxidants such as BHT and vitamins E and C. Furthermore, the extracts demonstrated moderate antimicrobial and high cytotoxic activity against selected microbial strains and Artemia salina, respectively, as well as potent antalgic effects comparable to paracetamol (88.35%). The findings highlight the value of I. viscosa roots as a natural resource for a variety of industries, including pharmaceuticals, cosmetics, and agriculture. Its antioxidant and antimicrobial properties make it an appealing candidate for use as a natural preservative.

An innovative approach for lipid-rich food preservation: peanut skin microcapsules [PMID: 39828415 · 2025]
Bergesse AE, Camiletti OF, Prieto MC, et al. · J Food Sci (2025)

This study evaluates the microencapsulation of peanut skin phenolic compounds by spray drying, assessing their physicochemical properties and storage stability and the protective effect against oxidative deterioration in walnut kernels. Extraction yield, total phenolic content, and HPLC-ESI-MS/MS analysis were performed on peanut skin crude extract (PCE). Microencapsulation of PCE with 10%, 20%, and 30% maltodextrin via spray drying was conducted. The drying yield, phenolic encapsulation efficiency, moisture content, morphology, particle size, and stability during dry storage (23&#xb0;C) and in water (23 and 100&#xb0;C) were assessed for the microcapsules. PCE contained 950.29&#xa0;mg GAE/g of total polyphenolic compounds, primarily hydroxycinnamic acid-derived phenolic acids and procyanidins. Microcapsules with 20% maltodextrin exhibited the best properties (drying yield, encapsulation efficiency, and stability). These microcapsules were incorporated into an edible chickpea-based coating, which was applied to walnuts and stored at 40&#xb0;C for 15 days. Peroxide value, conjugated dienes, volatile compounds, and fatty acid profile were analyzed on samples from storage. The chickpea-based coating combined with PCE microcapsules effectively preserves walnut quality during storage, offering a viable and natural alternative to synthetic antioxidants such as BHT, addressing current concerns in food preservation. PRACTICAL APPLICATION: Peanut skins are a byproduct of the peanut industry with low commercial value. These skins are rich in polyphenols, which exhibit potent antioxidant activity. This study investigates the microencapsulation of polyphenolic peanut extract and its incorporation into a chickpea-based edible coating. The prepared coating demonstrated a remarkable protective effect against lipid oxidation in walnuts, extending their shelf life. These findings present a sustainable strategy that adds value to agro-industrial residues and aligns with circular economy principles. This innovation offers a natural and effective solution to enhance the stability and quality of lipid-rich foods.

자주 묻는 질문 (AEO 스니펫 최적화 FAQ)

Q1. 비에이치티 (BHT)의 국가별 공식 전성분 표기명은 어떻게 다른가요?
한국 식약처 표준명은 '비에이치티', 미국 PCPC 및 유럽 CosIng INCI 표기는 'BHT', 중국 NMPA IECIC 표준명은 '丁羟甲苯', 일본 화장품 표시명칭은 'BHT'입니다.
Q2. 비에이치티의 글로벌 6대 권역 법정 배합 한도(Layer 1)는 무엇인가요?
한국(KR: none), 유럽(EU: restricted), 미국(US: none), 중국(CN: allowed), 일본(JP: none), 아세안(ASEAN: none) 고시 기준을 준수하여 처방해야 합니다.
Q3. 제형 설계 시 비에이치티의 통상 배합 농도(Layer 3)와 적정 pH는 얼마인가요?
대표 제형군(emulsion_cream) 기준 통상 0.02~0.5%(권장 중앙값 0.02%) 범위로 투입하며, 적정 pH는 4~8입니다.
Q4. 비에이치티 배합 시 주의해야 할 상용성 금기(Incompatibilities)와 시너지 성분은 무엇인가요?
주요 권장 시너지 조합은 GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL이며, 배합 주의사항은 처방 내 극단적 pH 조건 및 고농도 전해질과의 상용성 사전 확인 권장입니다.